CRISPR Therapeutics AG (CRSP)
51.52
+1.30
(+2.59%)
USD |
NASDAQ |
Oct 15, 16:00
51.55
+0.03
(+0.06%)
After-Hours: 04:38
CRISPR Therapeutics Cash from Operations (TTM) : -369.58M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -369.58M |
| March 31, 2026 | -399.96M |
| December 31, 2025 | -345.01M |
| September 30, 2025 | -302.49M |
| June 30, 2025 | -324.77M |
| March 31, 2025 | -306.47M |
| December 31, 2024 | -142.77M |
| September 30, 2024 | -188.82M |
| June 30, 2024 | -121.76M |
| March 31, 2024 | -159.42M |
| December 31, 2023 | -260.38M |
| September 30, 2023 | -277.63M |
| June 30, 2023 | -342.99M |
| March 31, 2023 | -351.70M |
| December 31, 2022 | -495.74M |
| September 30, 2022 | -468.45M |
| June 30, 2022 | -444.56M |
| March 31, 2022 | 504.40M |
| December 31, 2021 | 538.97M |
| September 30, 2021 | 543.80M |
| Date | Value |
|---|---|
| June 30, 2021 | 549.43M |
| March 31, 2021 | -286.85M |
| December 31, 2020 | -238.37M |
| September 30, 2020 | -153.78M |
| June 30, 2020 | 55.34M |
| March 31, 2020 | 48.24M |
| December 31, 2019 | 56.68M |
| September 30, 2019 | 24.93M |
| June 30, 2019 | -128.46M |
| March 31, 2019 | -117.29M |
| December 31, 2018 | -96.24M |
| September 30, 2018 | -82.71M |
| June 30, 2018 | -78.61M |
| March 31, 2018 | -69.37M |
| December 31, 2017 | -70.09M |
| September 30, 2017 | -77.12M |
| June 30, 2017 | -71.08M |
| March 31, 2017 | -68.71M |
| December 31, 2016 | -55.31M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Vertex Pharmaceuticals, Inc. | 4.293B |
| Basilea Pharmaceutica AG | 75.01M |
| Santhera Pharmaceuticals Holding AG | -0.7361M |
| BeOne Medicines Ltd. | 1.488B |
| AC Immune SA | -- |